Pediatrix Medical Group Announces 47th Annual NEO: The Conference for Neonatology

Key Terms

neonatal-perinatal medicine medical

Neonatal-perinatal medicine is the medical specialty focused on the health of newborn infants and the care of mothers during the period immediately before and after birth, especially for high-risk pregnancies and fragile babies. Think of it as a specialized intensive care unit and care team for newborns and their mothers; for investors, advances, devices, drugs or hospital capacity in this area can drive demand, affect reimbursement, and influence clinical trial and regulatory risk that impact company valuation.

neonatology medical

Neonatology is the branch of medicine focused on the care of newborn infants, especially those who are premature, sick, or born with medical problems. For investors, it matters because demand for neonatal care drives spending on specialized hospital units, equipment, drugs, and staffing; improvements in treatments or technology can change patient outcomes, costs, reimbursement and the market prospects for healthcare companies — like upgrading from a basic crib to a high-tech incubator.

preterm birth medical

Birth that occurs before 37 completed weeks of pregnancy, when a baby’s organs—especially the lungs and brain—may still be immature and require extra medical care. Investors should care because preterm birth drives demand for neonatal medicines, devices and hospital services, influences health-care spending and insurance costs, and shapes the size and timing of markets for treatments and technologies—like an unexpected early arrival that strains resources and changes spending patterns.

patent ductus arteriosus medical

A congenital heart condition where a blood vessel that normally closes soon after birth stays open, letting extra blood flow between two major arteries; imagine a door that should have shut after a baby is born but remains ajar and forces the heart and lungs to work harder. It matters to investors because the condition drives demand for specific drugs, medical devices and procedures, and outcomes from clinical trials or regulatory approvals can directly affect companies’ revenues and valuations.

neonatal respiratory care medical

Neonatal respiratory care is the range of treatments and equipment used to help newborns—especially premature infants—breathe and get oxygen, from simple oxygen support to ventilators, inhaled medicines, monitoring devices and specialized nursing. Investors pay attention because demand, regulatory approvals and technological improvements for these products influence hospital spending, product sales and patient outcomes, much like safety features on cars shaping markets for manufacturers and insurers.

point-of-care ultrasound medical

Point-of-care ultrasound is a portable imaging tool used by clinicians at the bedside, in clinics or in the field to produce real-time pictures of organs, blood flow or injuries—think of it as a pocket-sized camera for seeing inside the body. It matters to investors because these devices can speed diagnosis, lower costs, shift volumes away from large imaging centers, and create sales and service opportunities for medical device and software companies, affecting growth and margins.

neonatal resuscitation medical

Neonatal resuscitation is the emergency care given to a newborn who is not breathing or has trouble breathing at birth, using simple steps like clearing airways, stimulating breathing, providing oxygen or gentle ventilation, and sometimes chest compressions. Investors care because the frequency of these interventions, and the devices, training programs and drugs used in them, affect demand, regulatory scrutiny, reimbursement and sales prospects for companies serving hospitals and birthing centers—much like how a recall or safety standard can reshape demand for car airbags.

Leading Educational Event Brings Together Neonatal-Perinatal Medicine Clinicians Dedicated to Improving Outcomes in Newborn Care

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)-- Pediatrix^® Medical Group, Inc. (NYSE: MD), a leading provider of physician services, is proud to host the 47^th annual NEO: The Conference for Neonatology, taking place Feb. 25-27 in Las Vegas. NEO brings together top neonatology experts to discuss current issues and new advances in neonatal medicine.

For over 45 years, Pediatrix has been a trusted leader in neonatology, caring for or providing diagnostics to approximately one-quarter of all newborn babies in the U.S.

The national rate of preterm birth remains at an all-time high at 10.4%, meaning about 380,000 babies – one in every ten – were born prematurely in 2024. The March of Dimes’ 2025 Report Card, released in November, revealed that the nation received a D+ grade for preterm births for the fourth year in a row.

“These results underscore the ongoing need for innovation in neonatal-perinatal medicine,” said Timothy Biela, M.D., a neonatologist at Pediatrix Neonatology of San Antonio and director of the NEO conference. “We take pride in leading research initiatives and offering continuing education not only for our own clinicians but also for all providers involved in this highly specialized field. Our goal is to enhance outcomes for our tiniest, highest-risk patients.”

Conference Overview

This year’s conference welcomes participants from across the globe to engage with leading experts who will share the latest research, innovations and pressing topics in neonatal-perinatal medicine. Attendees will gain insights from distinguished speakers and participate in interactive sessions designed to foster learning and collaboration among clinicians.

Session Highlights

• Transforming Outcomes for Mothers and Babies
• Neonatal Surgery and Nutrition: Bridging Innovation and Outcomes
• Patent Ductus Arteriosus Management: Medical vs. Surgical
• Ethical Considerations in Neonatal Care
• From Oxygen to Artificial Intelligence: The Future of Neonatal Respiratory Care
• Advancements in Neonatal Nutrition
• Neonatal Point-of-Care Ultrasound (POCUS) Pre-Conference Workshop

These sessions are designed to address both clinical excellence and the evolving challenges faced by neonatal-perinatal teams. The Neonatal POCUS Pre-Conference Workshop offers hands-on experience with cutting-edge ultrasound techniques, supporting the advancement of bedside diagnostics and care.

Legends of Neonatology Hall of Fame

Pediatrix is honored to announce that Waldemar Carlo, M.D., will be inducted into the Legends of Neonatology Hall of Fame during the conference. Dr. Carlo is celebrated for his pioneering research in neonatal resuscitation, global health initiatives and commitment to improving neonatal outcomes worldwide. His work has influenced clinical protocols and shaped the next generation of neonatal care providers.

Accreditation

Participants attending the NEO conference will have the opportunity to earn accredited continuing education credits. The Pediatrix Center for Research, Education, Quality and Safety is accredited by:

• The Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians, designating this live activity for a maximum of 20.00 AMA PRA Category 1 Credits™.
• The American Nurses Credentialing Center’s Commission on Accreditation as a provider of nursing continuing professional development, designating this live activity for a maximum of 20.00 nursing contact hours.

About Pediatrix Medical Group

Pediatrix^® Medical Group, Inc. (NYSE:MD) is a leading provider of physician services. Pediatrix-affiliated clinicians are committed to providing coordinated, compassionate and clinically excellent services to women, babies and children across the continuum of care, both in hospital settings and office-based practices. Specialties include obstetrics, maternal-fetal medicine and neonatology complemented by multiple pediatric subspecialties. The group’s high-quality, evidence-based care is bolstered by significant investments in research, education, quality-improvement and safety initiatives. The physician-led company was founded in 1979 as a single neonatology practice and today provides its highly specialized and often critical care services through approximately 4,300 affiliated physicians and other clinicians. To learn more about Pediatrix, visit www.pediatrix.com or follow us on Facebook, Instagram, LinkedIn and the Pediatrix blog. Investment information can be found at www.pediatrix.com/investors.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260223873892/en/

For media inquiries, please contact:

communications@pediatrix.com

Source: Pediatrix Medical Group, Inc.